Direct medical costs associated with using vancomycin in methicillin-resistant Staphyloccoccus aureus infections: An economic model | Abt Associates

Skip to main content

This page is optimized for a taller screen. Please rotate your device or increase the size of your browser window.

Direct medical costs associated with using vancomycin in methicillin-resistant <em>Staphyloccoccus aureus</em> infections: An economic model

Shah NP, Reddy P, Paladino JA, McKinnon PS, Klepser ME, Pashos CL

Article